Sorrento Investors Rip Atty Fee Requests Over 'Scant' Results
A group of Sorrento Therapeutics Inc. shareholders has asked a Texas bankruptcy judge to reject $50 million in fee applications by lawyers for the drug developer, charging that the Chapter 11...To view the full article, register now.
Already a subscriber? Click here to view full article